Reference market
Closed- Regular hours
- 09:30 AM – 04:00 PM EST
- Next holiday
- Nov 26, 2026 · Thanksgiving Day
Equity
ALB perpetual futures on 1 crypto exchange – live perp price vs the stock, funding rate, open interest and where to trade ALBUSDT.
Albemarle produces engineered specialty chemicals through Lithium, Bromine and Catalysts segments, serving energy storage, refining, electronics, pharmaceuticals and other industries worldwide.
Use the left and right arrow keys to inspect points on the chart.
Trading data
Some venue links are sponsored. We may receive a commission, and eligible users may occasionally receive trading-fee discounts, at no additional cost to you.
Tokenized wrappers of the real stock, tradable on-chain and on crypto exchanges around the clock. Premium/discount compares the token price to our stock reference price. Data: CoinMarketCap · Robinhood · DexScreener · GeckoTerminal.
| Product | Price | Premium vs stock | 24h Vol. | Market Cap | Chains |
|---|---|---|---|---|---|
| ALBonOndo GM | $96.08 | -0.99% | $6 | $3k | Solana · Ethereum · BNB Smart Chain (BEP20) |
Tradability
No sufficient depth · 0 of 1 venues absorb $10k
No fresh book data: Gate.io
Taker execution estimate incl. approx. fees - maker fills are not guaranteed.
Next catalyst
No unusual perp activity right now.
Reference data
Research data
| Consensus rating | Buy |
|---|---|
| Average price target | $164.82 |
| Target range (low – high) | $109 – $250 |
| Ratings counted | 46 |
| Month | Strong buy | Buy | Hold | Sell | Strong sell |
|---|---|---|---|---|---|
| Nov 2026 | 3 | 12 | 9 | 0 | 0 |
| Oct 2026 | 3 | 12 | 10 | 0 | 0 |
| Sep 2026 | 3 | 10 | 9 | 0 | 0 |
| Aug 2026 | 3 | 10 | 9 | 0 | 0 |
| Jul 2026 | 3 | 10 | 10 | 0 | 0 |
| Jun 2026 | 3 | 11 | 12 | 0 | 0 |
| May 2026 | 2 | 10 | 13 | 0 | 0 |
| Apr 2026 | 2 | 11 | 13 | 0 | 0 |
| Mar 2026 | 2 | 11 | 12 | 0 | 0 |
| Feb 2026 | 2 | 11 | 14 | 0 | 0 |
| Jan 2026 | 2 | 10 | 18 | 0 | 0 |
| Dec 2025 | 1 | 7 | 18 | 2 | 0 |
Albemarle CFO Neal Ravi Sheorey had 849 common shares withheld to cover taxes at $99.25 per share on Nov 6, 2026, leaving 20,082 shares directly owned.
Director Alejandro Daniel Wolff received a 45-share Common Stock award (A-Award) on 2026-10-01 at $0.00, bringing ownership to 13,089 shares, per Form 4 filed 2026-10-02.
Albemarle officer Eric Norris received a grant (A-Award) of 10,867 common shares at $0.00 on 2026-09-14, an award rather than a purchase, leaving 64,310 shares owned.
Albemarle COO Mark Richard Mummert received a grant (A-Award) of 6,086 common shares at $0.00 on 2026-09-14, bringing his holdings to 23,601 shares. Form 4 filed 2026-09-16.
Albemarle officer Autumn M. Gagarinas received a 5,217-share common stock award on Sept 14, 2026, bringing her holdings to 10,610 shares.
Albemarle officer Max Hood (Chief Accounting Officer) received an award of 1,476 common shares on 2026-09-01, at $0.00, leaving him with 1,476 shares. This was a grant, not an open-market purchase.
Albemarle officer Max Hood filed a Form 3 on 2026-08-25 reporting a transaction dated 2026-08-24 with no shares acquired or disposed and no holdings after. No transaction code was specified, so no purchase or sale is indicated.
Director Bartolomeo Eduardo Desalles received a grant of 1,375 shares of Albemarle common stock on 2026-07-21 (A-Award, not an open-market purchase), bringing his holding to 1,375 shares. The Form 4 was filed 2026-07-23.
Albemarle director Bartolomeo Eduardo DeSalles filed an initial Form 3 on 2026-07-23 disclosing no shares of common stock acquired and no holdings after the transaction dated 2026-07-21.
Albemarle director Glenda J. Minor received an award of 1,250 phantom stock shares on July 1, 2026, at $0.00 (a grant, not a purchase), bringing her reported holdings to 5,606 shares.
Albemarle director Michelle T Collins received 1,252 shares of common stock in 2 award grants on 2026-07-01, at $0.00 per share. She held 1,575-1,577 shares afterward.
Albemarle director Cramer Ralf Hans was granted 1,286 shares of Common Stock (A-Award) on 2026-07-01, and 942 shares were withheld for taxes at $136.08 (F-InKind).
Albemarle director Laurie Brlas acquired 1,286 common shares via two stock awards (A) on 2026-07-01 at $0.00; these are grants, not open-market purchases. She held 7,289 shares after.
Albemarle director Wolff Alejandro Daniel received awards of 33 common shares and 1,250 phantom stock shares on 2026-07-01, both grants at $0.00. After the awards he held 13,044 common shares and 7,590 phantom shares.
Albemarle director Mark R. Widmar received 1,250 phantom stock units as an award (code A) on 2026-07-01, after which he held 1,576. This is a grant, not an open-market purchase.
Director Gerald A. Steiner received an award of 1,286 shares of Albemarle common stock on July 1, 2026, in two granted transactions at $0.00, leaving 13,232 shares owned after the award.
Albemarle director Holly Van Deursen received an award of 1,250 phantom stock shares on July 1, 2026, at $0.00; she then held 10,028 such shares. This is compensation, not an open-market purchase.
Albemarle director Diarmuid B. O'Connell received a grant of 36 common shares on 2026-07-01 under code A (award), not a purchase, and holds 8,626 shares after.
Albemarle CFO Neal Ravi Sheorey had 849 common shares withheld to cover taxes at $99.25 per share on Nov 6, 2026, leaving 20,082 shares directly owned.
Director Alejandro Daniel Wolff received a 45-share Common Stock award (A-Award) on 2026-10-01 at $0.00, bringing ownership to 13,089 shares, per Form 4 filed 2026-10-02.
Albemarle officer Eric Norris received a grant (A-Award) of 10,867 common shares at $0.00 on 2026-09-14, an award rather than a purchase, leaving 64,310 shares owned.
Albemarle COO Mark Richard Mummert received a grant (A-Award) of 6,086 common shares at $0.00 on 2026-09-14, bringing his holdings to 23,601 shares. Form 4 filed 2026-09-16.
Albemarle officer Autumn M. Gagarinas received a 5,217-share common stock award on Sept 14, 2026, bringing her holdings to 10,610 shares.
Albemarle officer Max Hood (Chief Accounting Officer) received an award of 1,476 common shares on 2026-09-01, at $0.00, leaving him with 1,476 shares. This was a grant, not an open-market purchase.
Albemarle officer Max Hood filed a Form 3 on 2026-08-25 reporting a transaction dated 2026-08-24 with no shares acquired or disposed and no holdings after. No transaction code was specified, so no purchase or sale is indicated.
Director Bartolomeo Eduardo Desalles received a grant of 1,375 shares of Albemarle common stock on 2026-07-21 (A-Award, not an open-market purchase), bringing his holding to 1,375 shares. The Form 4 was filed 2026-07-23.
Albemarle director Bartolomeo Eduardo DeSalles filed an initial Form 3 on 2026-07-23 disclosing no shares of common stock acquired and no holdings after the transaction dated 2026-07-21.
Albemarle director Holly Van Deursen received an award of 1,250 phantom stock shares on July 1, 2026, at $0.00; she then held 10,028 such shares. This is compensation, not an open-market purchase.
Albemarle director Michelle T Collins received 1,252 shares of common stock in 2 award grants on 2026-07-01, at $0.00 per share. She held 1,575-1,577 shares afterward.
Albemarle director Cramer Ralf Hans was granted 1,286 shares of Common Stock (A-Award) on 2026-07-01, and 942 shares were withheld for taxes at $136.08 (F-InKind).
Albemarle director Mark R. Widmar received 1,250 phantom stock units as an award (code A) on 2026-07-01, after which he held 1,576. This is a grant, not an open-market purchase.
Albemarle director Laurie Brlas acquired 1,286 common shares via two stock awards (A) on 2026-07-01 at $0.00; these are grants, not open-market purchases. She held 7,289 shares after.
Albemarle director Wolff Alejandro Daniel received awards of 33 common shares and 1,250 phantom stock shares on 2026-07-01, both grants at $0.00. After the awards he held 13,044 common shares and 7,590 phantom shares.
Director Gerald A. Steiner received an award of 1,286 shares of Albemarle common stock on July 1, 2026, in two granted transactions at $0.00, leaving 13,232 shares owned after the award.
Albemarle director Glenda J. Minor received an award of 1,250 phantom stock shares on July 1, 2026, at $0.00 (a grant, not a purchase), bringing her reported holdings to 5,606 shares.
Albemarle director Diarmuid B. O'Connell received a grant of 36 common shares on 2026-07-01 under code A (award), not a purchase, and holds 8,626 shares after.
Albemarle director and CEO J Kent Masters sold 16,393 Common Stock shares in 3 open-market transactions at $183.12-$184.52 on 2026-05-15, leaving 87,519 shares owned.
Company data
| Fund | Weight | Shares held |
|---|---|---|
| VTI | 0.02% | 3.8M |
| VOO | 0.02% | 3.1M |
| PFF | 0.96% | 2.7M |
| VB | 0.16% | 2.7M |
| VECA.S | 0.04% | 2.1M |
| FXAIX | 0.02% | 1.8M |
| NOBL | 1.36% | 1.8M |
| VPMAX | 0.18% | 1.6M |
| IVV | 0.02% | 1.6M |
| XSP.TO | 0.02% | 1.6M |
| RSP | 0.14% | 1.6M |
| XLB | 1.66% | 1.5M |
How the analysts covering ALB have done: ratings, price-target accuracy and the measured reaction after their calls.
| 12 months | 3 years | |
|---|---|---|
| Ratings | 123 | 392 |
| Analysts | 25 | 35 |
| Buy / hold / sell | 69 / 54 / 0 | 182 / 186 / 24 |
| Upgrades / downgrades / initiations | 11 / 3 / 2 | 15 / 15 / 6 |
| Price targets hit / missed | 1 / 121 (1%) | 103 / 278 (27%) |
| Avg. return after a rating (TipRanks) | -43.1% | -18.2% |
| Best / worst call | +1.0% / -63.7% | +68.4% / -63.7% |
After buy calls on this stock: median 21-day move -2.4% (n = 198) vs S&P 500 -4.8% (n = 197)
Share of an analyst's price targets on this stock that the price reached within 12 months (our measurement over the last 3 years, at least 8 targets). It describes past calls, not the odds of the current one.
| Date | Analyst | Call | Target | |
|---|---|---|---|---|
| Nov 9, 2026 | David BegleiterDeutsche BankNov 9, 2026 | BuyMaintained | $125↗ | article ↗ |
| Nov 9, 2026 | Joshua SpectorUBSNov 9, 2026 | BuyMaintained | $137↗ | article ↗ |
| Nov 9, 2026 | Ben IsaacsonScotiabankNov 9, 2026 | BuyMaintained | $165↗ | article ↗ |
| Nov 9, 2026 | Vincent AndrewsMorgan StanleyNov 9, 2026 | HoldReiterated | $105↗ | article ↗ |
| Nov 9, 2026 | Patrick CunninghamCitiNov 9, 2026 | BuyMaintained | $140↗ | article ↗ |
Share of analysts per call each month (latest call per analyst within 180 days). Targets and closes in USD.
TipRanks data · computed Nov 12, 2026 · 123 ratings
Albemarle Corporation (ALB) perpetual futures trade on one crypto venue: Gate.io. PerpEquities shows its live price, funding rate, open interest and liquidity.
Yes. Unlike the underlying stock, ALB perpetuals trade 24/7 — including weekends and outside regular market hours.
Right now the ALB perp funding rate is 0.0% annualized (one venue). A positive rate means longs pay shorts. PerpEquities shows the live rate and its history.
The venue-median ALB perp mark is $97 versus a reference stock price of $97, a basis of 0.0%. Perps follow the stock through an index price; the gap widens when funding or liquidity diverge between venues.
A ALB perpetual is a derivative that tracks the price of Albemarle Corporation with no expiry date. It lets you take long or short exposure to Albemarle Corporation on crypto venues, around the clock.
ALBUSDT is the symbol most crypto exchanges use for the Albemarle Corporation perpetual settled in USDT (Tether). It tracks the ALB share price through an index, trades 24/7 with leverage and never expires.